More NewsRead More
Corcept Therapeutics Announces Poster Presentations on Mifepristone for the Treatment of Patients With Cushing's Syndrome at the 27th Annual American Association of Clinical Endocrinologists
May 14, 2015
Corcept Therapeutics' Mifepristone Combined With Eribulin to Improve Antitumor Activity in Patients With Triple-Negative Breast Cancer
May 13, 2015
Corcept Therapeutics Announces First Quarter 2015 Results and Provides Corporate Update
May 07, 2015
Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call
April 30, 2015
Warrant Exercises Generate $17.2 Million; Proceeds to Advance Next-Generation Compounds and Support Commercialization of Korlym(R)
April 01, 2015
Corcept Therapeutics Announces Nine Poster Presentations on Mifepristone for the Treatment of Cushing's Syndrome at the 97th Annual Endocrine Society Meeting
March 05, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here